Vincerx Pharma, Inc. Current Assets
Vincerx Pharma, Inc. had Current Assets of $4.69 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-05-15
- 2025-03-31: Assets, Current $4.69M.
- 2024-12-31: Assets, Current $6.41M.
- 2024-09-30: Assets, Current $11.75M.
- 2024-06-30: Assets, Current $18.28M.
| Period end | Assets, Current |
|---|---|
| 2025-03-31 | $4.69M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $6.41M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $11.75M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $18.28M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $7.68M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $14.73M 10-K · filed 2025-03-27 |
| 2023-09-30 | $22.82M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $31.81M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $44.01M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $55.96M 10-K · filed 2024-03-29 |
| 2022-09-30 | $67.25M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $82.39M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $98.06M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $111.84M 10-K · filed 2023-03-28 |
| 2021-09-30 | $123.25M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $86.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $54.41M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $63.11M 10-K · filed 2022-03-29 |
| 2020-09-30 | $636.70K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $791.04K 10-Q · filed 2020-11-10 |
| 2020-03-31 | $844.66K 10-Q · filed 2020-05-06 |
| 2019-06-30 | $25.00K 10-K · filed 2020-09-23 |